(Q34777681)

English

Dementia epidemiology

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Dementia epidemiology (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

1 reference

based on heuristic

inferred from title

Walter A. Kukull

object named as

Walter A Kukull

1

0 references

2

object named as

James D Bowen

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Medical Clinics of North America

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

573-590

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Epidemiology of dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The construct validity of the ischemic score of Hachinski for the detection of dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Hachinski's ischemic score and the diagnosis of vascular dementia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Prevalence and outcomes of vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Headache in a population-based elderly cohort. An ancillary study to the Italian Longitudinal Study of Aging (ILSA).

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The incidence of dementia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Vascular risks and incident dementia: results from a cohort study of the very old.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Undifferentiated dementia, Alzheimer's disease and vascular dementia: age- and gender-related incidence in Liverpool. The MRC-ALPHA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The prognosis of mild cognitive impairment in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Early diagnosis of Alzheimer dementia based on clinical and biological factors

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Early-life risk factors and the development of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Smoking and Alzheimer's disease: a review of the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The influence of smoking on the risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Smoking and dementia in male British doctors: prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The EURODEM collaborative re-analysis of case-control studies of Alzheimer's disease: implications for public health

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Alzheimer's disease in 22 twin pairs--13-year follow-up: hormonal, infectious and traumatic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Alzheimer's disease after remote head injury: an incidence study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Rate of memory decline in AD is related to education and occupation: cognitive reserve?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Incidence and risk of dementia. The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Educational attainment and socioeconomic status of patients with autopsy-confirmed Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Risk factors and differential diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Low education and childhood rural residence: risk for Alzheimer's disease in African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Education and incident Alzheimer's disease: a biased association due to selective attrition and use of a two-step diagnostic procedure?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Cognitive reserve and mortality in dementia: the role of cognition, functional ability and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Sensitivity and specificity of some neuropsychological markers of Alzheimer dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Ibuprofen: effect on inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

NSAIDs and incident Alzheimer’s disease. the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen use and early onset Alzheimer's disease: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Alzheimer disease: protective factors

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen, cognition, and a woman's risk of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The epidemiology of estrogen replacement therapy and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Genetic risk factors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The gene defects responsible for familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Molecular genetics of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Alzheimer's disease: perspectives for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Genes and susceptible loci of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Alzheimer's disease: genetic studies and transgenic models

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Recent advances in the genetics of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

The role of presenilin-1 in the gamma-secretase cleavage of the amyloid precursor protein of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Four companies announce discovery of beta-secretase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Purification and cloning of amyloid precursor protein beta-secretase from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

APOE is a major susceptibility gene for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Alpha2 macroglobulin and the risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

No association between the HLA-A2 allele and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Mutation screening of the tau gene in patients with early-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Mitochondrial genome lesions in the pathogenesis of sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Mitochondrial DNA mutations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Mutations in the Tau gene cause frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

A polymorphism in the tau gene associated with risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

Operational criteria for senile dementia of Lewy body type (SDLT)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A historical review of the concept of vascular dementia: lessons from the past for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900010-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0025-7125(02)00010-X

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34777681&oldid=1977144723"